TTRX — Turn Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Turn Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -4.29 | -3.08 | -1.77 | -3.19 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 1.93 | 1.47 | 0.361 | -1.79 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 1.1 | 0.172 | -0.002 | 2.37 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Net Change in Other Assets & Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -1.21 | -1.38 | -1.36 | -2.56 |
| Capital Expenditures | -0.018 | -0.044 | -0.099 | -0.153 |
| Purchase / Acquisition of Intangibles | ||||
| Cash from Investing Activities | -0.018 | -0.044 | -0.099 | -0.153 |
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 0.35 | 0.5 | 1.15 | 6.92 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.874 | -0.922 | -0.308 | 4.2 |